Clinical Trials

Adenocarcinoma, Stomach Neoplasms

NCT01726582 2023-08-14

Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine")

229 enrolled 14 charts

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01660711 2021-11-08

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

22 enrolled 8 charts

Adenocarcinoma, Neoplasms

NCT01442935 2021-06-18

Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases

256 enrolled

Adenocarcinoma, Colorectal Neoplasms

NCT01217060 2021-04-13

Trimodality Management of T1b Esophageal Cancers

Phase 1/2 Completed

4 enrolled 8 charts

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT01652976 2021-01-05

FOLFOX-D

44 enrolled 18 charts

Adenocarcinoma, Neoplasm Metastasis, Pancreatic Neoplasms

NCT03207724 2020-12-30

OnFX

16 enrolled

Adenocarcinoma, Cachexia, Disease, Pancreatic Neoplasms, Weight Loss

NCT00515411 2019-12-10

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

111 enrolled 11 charts

Adenocarcinoma, Stomach Neoplasms

NCT02620800 2019-10-22

FABLOx

12 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT01206530 2019-04-18

FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal Cancer

Phase 1/2 Completed

50 enrolled

Adenocarcinoma, Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms

NCT01504256 2018-01-23

CatuNeo

42 enrolled

Gynecologic

Adenocarcinoma, Peritoneal Neoplasms

NCT01383538 2017-08-08

FOLFIRINOX Plus IPI-926 for Advanced Pancreatic Adenocarcinoma

15 enrolled

Adenocarcinoma, Neoplasms, Pancreatic Neoplasms

NCT01472029 2017-06-19

HerFLOT

53 enrolled

Adenocarcinoma

NCT00548548 2017-06-14

AVAGAST

Phase 3 Completed

774 enrolled 14 charts

Adenocarcinoma

NCT01376453 2016-09-12

Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal Cancer

18 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT00499850 2016-08-25

Phase I FOLFOX Combination

18 enrolled

Adenocarcinoma

NCT00507091 2016-08-25

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

24 enrolled

Adenocarcinoma, Neoplasm Metastasis

NCT01932580 2015-10-27

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

10 enrolled

Adenocarcinoma Of Esophagus, Adenocarcinoma

NCT01554059 2014-11-10

New Beat

25 enrolled

Adenocarcinoma, Rectal Neoplasms

NCT01523015 2013-02-05

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Phase 2/3 Unknown

100 enrolled

Adenocarcinoma

NCT00368329 2012-07-16

Phase I Dose Escalation of Stereotactic Radiosurgical Boost for Locally Advanced Esophageal Cancer

Phase 1 Terminated

4 enrolled

Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT01175291 2011-12-05

FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal Cancer

Phase 2 Withdrawn

Adenocarcinoma, Neoplasm Metastasis, Colorectal Neoplasms

NCT00001569 2008-03-04

Phase I Trial of Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin Plus Early Postoperative Intraperitoneal Paclitaxel and 5-FU for Peritoneal Carcinomatosis

74 enrolled

Gynecologic

Adenocarcinoma, Carcinoma, Peritoneal Neoplasms

NCT00054873 2006-07-11

Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer